Invitation: Roche’s Virtual Hematology Investor Event Donnerstag, 30. Mai 2024 - 14:07

Investor Update

Invitation: Roche's Virtual Hematology Investor Event

We are pleased to invite investors and analysts to participate in our virtual event on Sunday, 16 June 2024, to highlight Ph III STARGLO results in 2L+ DLBCL presented during the EHA congress and provide an update in non-malignant hematology.

13:00 – 14:00 CEST / 12:00 – 13:00 BST

07:00 – 08:00 am EDT / 04:00 – 05:00 am PDT

The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 12:00 CEST on the day of the event. > click here

Access to virtual event (pre-registration required)

Please pre-register for our webinar here*.

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

A replay of the webcast will be available via > ir.roche.com

*privacy notice

Best regards,

Bruno Eschli
Head of Investor Relations

Rishard Salie

Investor Relations Officer

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com

Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com